Clinical Trial Update: Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response

View source ↗

Summary

This completed clinical trial investigates how anti-TNF alpha therapies affect the surgical stress response in patients with inflammatory bowel diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Anti-Tumor Necrosis Factor Alpha Agents

Snippet

Sponsor: El-Hussuna, Alaa, M.D. | Conditions: Inflammatory Bowel Diseases | Status: COMPLETED